EHA Congress Highlights Middle East - PROGRAM

15:00-15:15

Opening

R. Foà, F. Lo Coco, A. Inati, A. Taher

UPDATES ON TREATMENT

15:15-16:45

Session I. Lymphoid Neoplasms

Chair: R. Foà (Italy)

1. MRD oriented treatment in Ph-neg adult ALL

Speaker: JM. Ribera (Spain)

2. Treatment of extranodal DLBCL

Speaker: F. Cavalli (Switzerland)

3. ACUTE LYMPHOBLASTIC LEUKAEMIA IN CHILDHOOD: OUTCOMES OF UNRELATED CORD BLOOD TRANSPLANT

Speaker: A. Ruggeri (France)

16:45-17:00

COFFEE/TEA BREAK

17:00-18:30

Session II. Myeloid Neoplams

Chair: F. Lo Coco (Italy)

1. Treatment of CML

Speaker: to be confirmed

2. Novel therapies in AML

Speaker: A.K. Burnett (UK)

3. Hematopoietic transplantation: Developing an alternative donor algorithm

Speaker: to be confirmed

09:30-11:00

Session III. Red cell diseases

Chair: A. Taher (Lebanon)

1. Thalassemia intermedia – Treatment Strategies

Speaker: A. Taher (Lebanon)

2. Management of PNH

Speaker: A. Hill (UK)

3. Molecular analysis in familial congenital erythrocytosis: novel mutations in EPOR and VHL genes

Speaker: L. Ribeiro (Portugal)

11:00-11:15

COFFEE/TEA BREAK

11:15-12:45

Session IV. Supportive care and complications

Chair: A. Inati (Lebanon)

1. Biological functions and new developments of ESA in management of anemia

Speaker: to be confirmed

2. Clinical trias in transfusion medicine

Speaker: A. Mijovic (UK)

3. Management of fungal infections

Speaker: G. Maschmeyer (Germany)

12:45-14:15

BUFFET LUNCH INCLUDING POSTERSWALKS

14:15-15:45

Session V. Supportive care, complications and pediatric hematology

Chair: A. Inati (Lebanon)

1. Management of thrombosis in cancer

Speaker: A. Falanga (Italy)

2. Clinical assessment of new anticoagulants

Speaker: M. Huisman (Netherlands)

3. ATRA and anthracycline based in APL

Speaker: R. Jeddi (Tunisia)

4. The risk of leukemia in genetic subgroups of congenital neutropenia

Speaker: C. Zeidler (Germany)

5. Presentation and outcome of children with ALL and Down’s syndrome. EORTC experience

Speaker: V. Mondelaers (Belgium)

6. Clofarabine in pediatric practice: UK experience

Speaker: D. O'Connor (The UK)

15:45-16:00

COFFEE/TEA BREAK

UPDATES ON BIOLOGY & TRANSLATIONAL RESEARCH

16:00-17:00

Session VI. Erythropoiesis and Iron

Chair: C. Camaschella (Italy)

1. Recent developments in molecular mechanisms of iron regulation

Speaker: C. Camaschella (Italy)

2. Switching genes on and off in hematopoiesis: New lessons from thalassemia

Speaker: D. Higgs (UK)

09:30-10:30

Session VII. Molecular ad imunophenotypic characterisation of leukemia

Chair: G. Saglio (Italy)

1. PCR analysis for classification and monitoring of AML

Speaker: G. Saglio (Italy)

2. Diagnostic classification of CLL and NHL using reference EuroFlow immunophenotypic databases

Speaker: to be confirmed

10:30-10:45

Session Honour the speakers

10:45-11:00

COFFEE/TEA BREAK

11:00-12:30

Session VIII. Bleeding disorders

Chair: A. Federici (Italy)

1. Overview of Bleeding Disorders

Speaker: A. Federici (Italy)

2. CURRENT CHALLENGES IN THE MANAGEMENT OF INHERITTED BLEEDING DISORDERS

Speaker: A. Federici (Italy)

12:30-13:45

Session IX. SELECTED ORAL PRESENTATIONS

Chair: to be confirmed

1. Dasatinib vs Imatinib

Speaker: G. Saglio (Italy)

2. Impact of allogeneic stem cell transplantation on tyrosine kinase domain mutations and minimal residual disease levels in patients with Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia

Speaker: to be confirmed

3. Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study

Speaker: to be confirmed

4. Efficacy of Rituximab in combination with Dexamethasone vs Dexamethasone in newly diagnosed patients with primary immune thrombocytopenia – an interim

Speaker: to be confirmed

5. 20mn Oral Dabigatran versus Enoxaparin for thromboprophylaxis after primary total hip arthroplasty: the RE-NOVATE II randomised trial

Speaker: M. Huo (USA)

13:45-15.15

FAREWELL LUNCH